🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

123+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 123 recruiting trials for “Systemic lupus erythematosus

Phase 1RecruitingNCT06581562

Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.

👨‍⚕️ Guillermo J. Valenzuela, M.D., IRIS Research and Development, LLC📍 1 site📅 Started May 2024View details ↗
NARecruitingNCT06379646

An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease

👨‍⚕️ Huji Xu, MD,Ph.D, Shanghai Changzheng Hospital📍 1 site📅 Started Apr 2024View details ↗
NARecruitingNCT06373081

Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease

👨‍⚕️ Huji Xu, Ph.D, MD, Shanghai Changzheng Hospital📍 1 site📅 Started Apr 2024View details ↗
NARecruitingNCT06308770

Fatigue in Lupus Intervention Programmes (FLIP)

👨‍⚕️ Helen Harris, BA MB BCh BAO, University of Edinburgh📍 1 site📅 Started Apr 2024View details ↗
NARecruitingNCT06361745

Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases

👨‍⚕️ songlou yin, master, The Affiliated Hospital of Xuzhou Medical University📍 1 site📅 Started Apr 2024View details ↗
Phase 1RecruitingNCT06249438

A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

👨‍⚕️ Nan Shen, MD & PhD, Department of Rheumatology, RenJi Hospital, School of Medicine, Shanghai JiaoTong University📍 1 site📅 Started Mar 2024View details ↗
Phase 1RecruitingNCT06285279

The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases

👨‍⚕️ Zhihong Liu, Jinling Hospital, China📍 1 site📅 Started Mar 2024View details ↗
RecruitingNCT06339957

Rheumatology Diet Study

👨‍⚕️ Neha Bhanusali, MD, University of Central Florida📍 1 site📅 Started Mar 2024View details ↗
Phase 1, PHASE2RecruitingNCT06106893

A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus Erythematosus

👨‍⚕️ Qiubai Li, Professor, Department of Rheumatology and Immunology, Wuhan Union Hospital📍 1 site📅 Started Jan 2024View details ↗
RecruitingNCT06458972

Safety and Efficacy of Telitacicept in the Treatment of Systemic Lupus Erythematosus (SLE)

👨‍⚕️ Dong Lingli, MD, Tongji Hospital📍 1 site📅 Started Jan 2024View details ↗
NARecruitingNCT05714930

LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus

👨‍⚕️ Matthias Schneider, MD, Heinrich-Heine University, Duesseldorf📍 14 sites📅 Started Dec 2023View details ↗
RecruitingNCT06462768

Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis

🏥 CHU de Reims📍 1 site📅 Started Nov 2023View details ↗
EARLY_Phase 1RecruitingNCT06010472

An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus

👨‍⚕️ Dongbao Zhao, Doctor, ChanghaiHospital📍 1 site📅 Started Aug 2023View details ↗
NARecruitingNCT05988216

Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus Erythematosus

🏥 Bioray Laboratories📍 1 site📅 Started Aug 2023View details ↗
RecruitingNCT05859191

Study of Neonatal IgG Fc Receptor Expression in Natural Killer T Cells Expressing an Invariant T Receptor : Implication in the Pathophysiology of Systemic Lupus

👨‍⚕️ Yanis RAMDANI, CHRU de Tours📍 1 site📅 Started Jul 2023View details ↗
Phase 1, PHASE2RecruitingNCT06347718

CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease

👨‍⚕️ Georg Schett, Prof. Dr. med. univ., Universitätsklinikum Erlangen📍 1 site📅 Started Jul 2023View details ↗
Phase 4RecruitingNCT05916781

Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus

👨‍⚕️ Mengtao Li, MD, Peking Union Medical College Hospital📍 1 site📅 Started Jul 2023View details ↗
RecruitingNCT05934149

Lupus Landmark Study: A Prospective Registry and Biorepository

👨‍⚕️ Sam Lim, MD, MPH, Emory University📍 21 sites📅 Started Jun 2023View details ↗
Phase 4RecruitingNCT05828147

Anti-CD20 Antibodies for Treatment of SLE-PAH

👨‍⚕️ Mengtao Li, Prof, Peking Union Medical College Hospital📍 1 site📅 Started May 2023View details ↗
NAEnrolling by InvitationNCT05859997

Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases

🏥 Bioray Laboratories📍 1 site📅 Started May 2023View details ↗
← PreviousPage 5 of 7Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →